The FINANCIAL -- People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune benefit after the second dose, according to new research from the Penn Institute of Immunology. The findings, published in Science Immunology, suggest only a single vaccine dose may be needed to produce a sufficient antibody response, according to University of Pennsylvania.…
Read More »
The FINANCIAL -- People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune benefit after the second dose, according to new research from the Penn Institute of Immunology. The findings, published in Science Immunology, suggest only a single vaccine dose may be needed to produce a…
You might be interested in
When the CDC’s eviction moratorium is lifted, 11 million Americans will face housing instability. As many as 11 million Americans currently…
Shvidi, a local company that has established itself on the Transcaucasian market as a major importer and distributor…
Many vaccinated adults have started going maskless, but most children still cannot. Some states are now fully open. According to…
Magistri, one of the leading security companies in Georgia, continues to offer exceptional security solutions to customers in Georgia: this…